EFSA’s statement on the safety of CBD 

EFSA’s statement on the safety of CBD 

The discussion about CBD continues, as EFSA is currently drafting a statement on the safety of cannabidiol (CBD) as a novel food, according to the EFSA register of question. This statement is issued on EFSA’s own initiative and is not associated with evaluations of...
Opinions of Health Claims 

Opinions of Health Claims 

This year, EFSA has published four opinions for the scientific substantiation of article 13(5) health claims. The following applications were evaluated: Beta-Glucans from oats/barley and reduction of blood-glucose rise  Affron and increase in positive...
Important innovations in Novel Foods

Important innovations in Novel Foods

In 2021, the European Commission published 16 implementing regulations concerning successful novel food applications. All novel food authorizations are listed in the union list. Five of these implementing acts concerned changes or extensions of existing novel...
Opinions of Health Claims 

Latest opinions on health claims

New EFSA opinions were published since October: Although the effect of isomaltulose on “normal energy-yielding metabolism” was confirmed by EFSA, the panel was unable to establish conditions of use. The background is that this effect is not...
Public consultation – Have your say!

Public consultation – Have your say!

In the beginning of 2021, EFSA was asked to provide a scientific opinion on harmonized front-of-pack nutrition labelling and the restriction of nutrition and health claims on food. The presented draft opinion considers three main aspects: 1) nutrients and...